secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001104659-23-118749
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acurx Pharmaceuticals enters $17M ATM equity offering with A.G.P.
-----------------------------------------------------------------

- Up to $17M of common stock may be sold from time to time in at-the-market offerings.
- A.G.P./Alliance Global Partners acts as sales agent, receiving 3% of gross proceeds.
- Sales may be made on Nasdaq Capital Market, OTC, or in negotiated transactions.
- Company is not obligated to sell any shares under the agreement.
- Offering made under existing Form S-3 shelf registration statement declared effective July 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465923118749/0001104659-23-118749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465923118749/tm2330856d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-118749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer